Professional experience in oncology circles, supported by multiple collaborations with major hospitals, allowed LOUIS CAZE to benefit from a reference fame as an Expert Support Care. First, Specialist lymphatic, muscular and circulatory LOUIS CAZE makes the total body approach his chosen field. It captures the benefits of physical-mental balance in the treatment of chronic diseases, and specializes in supportive care dedicated to cancer diseases. His collaboration with renowned organizations such as the Institute Gustave Roussy, was punctuated with exceptional professional and human experience. LOUIS CAZE is involved in implementing a comprehensive approach to cancer patient, in a real project of care that optimizes patient's quality of life, ensuring the different key aspects of health: the well physical and psychological, but also the entire social and family interactions. After these experiences, LOUIS CAZE work for the development of Support Care, including the management of pain and psychology

Dr. Aroldi is a medical oncology graduate at Catholic university of Sacred Heart in Rome and has conducted experiences in Switzerland and New York. She joined the early phase clinical trial unit at the University of Oxford as a Clinical Research Fellow in 2018 while she is undertaking an MSc in ‘Experimental and Translational Therapeutics”. I’m interested in developing novel translational studies that couple novel therapies with novel diagnostics applying them for the direct benefit of the patients. Therefore, in the last few years I have been involved in more than 50 phase I/II/III trials, written articles and presented posters at national and international congresses. The most recent have been accepted at the ESMO congress 2020 and SITC congress 2020.

FatihUckun, MD, PhDis the ChiefMedicalOfficer of RevenPharmaceuticalsand President of Ares Pharmaceuticals. Fatih M. Uckun, M.D., Ph.D, is an Active Member of the American Society for Clinical Investigation (ASCI), an honor society for physician-scientists, and an active member of several professional organizations, including ASCO and AACR. He earned his doctoral degrees at University of Heidelberg in Germany and completed his residency training in Pediatrics, fellowship training in Hematology/Oncology/Blood and Bone Marrow Stem Cell Transplantation, as well as postdoctoral research training in immunology at the University of Minnesota in the USA. Dr. Uckun has more than 30 years of professional experience in developmental therapeutics and biopharmaceuticals in oncology/immuno-oncology as well as infectious diseases and immunology. Dr. Uckun worked 11 years as a Professor of Bone Marrow Transplantation, Therapeutic Radiology-Radiation Oncology, Pharmacology, and Pediatrics as well as Director of the Biotherapy Institute at the University of Minnesota, where he became the first recipient of the Endowed Hughes Chair in Biotherapy. He worked 6 years as a Professor and Head of Translational Research in Leukemia and Lymphoma of the CCBD and a Principal Investigator of the Stem Cell-Regenerative Medicine Initiative at the at the University of Southern California. Dr. Uckunalsoservedas the Chair of the BiotargetingWorking Group of the NCI Alliance for Nanotechnology in Cancer. He has held executive positions in multiple biotechnology companies and has extensive regulatory experience. He has published more than 500 peer-reviewed papers and he has authored numerous review articles and book chapters. He received numerous awards including the Stohlman Memorial Award of the Leukemia Society of America (now known as the Leukemia and Lymphoma Society/LLS), the highest honor given to a Leukemia Society Scholar. He has served as a member of several editorial boards and NIH grant review/special emphasis panels.

Huang Wei Ling, born in Taiwan, raised and graduated in medicine in Brazil, specialist in infectious and parasitic diseases, a General Practitioner and Parenteral and Enteral Medical Nutrition Therapist. Once in charge of the Hospital Infection Control Service of the City of Franca’s General Hospital, she was responsible for the control of all prescribed antimicrobial medication and received an award for the best paper presented at the Brazilian Hospital Infection Control Congress in 1998. Since 1997, she works with the approach and treatment of all chronic diseases in a holistic way, with treatment guided through the teachings of Traditional Chinese Medicine and Hippocrates. Researcher in the University of São Paulo, in the Ophthalmology department from 2012 to 2013.

Dr. Rhim has served as an associate director and research professor of surgery in the department of surgery, the Center for Prostate Disease Research at the Uniformed Services University of the Health Sciences, in Bethesda, MD, a state-of-the-art translational research program that studies prostate cancer and prostate disease in the military healthcare system. Working in this capacity since 1999, he has also been a research professor in the department of surgery since 2000. Dr. Rhim spent 12 years as a project director of cancer research at Microbiology Associates, and 20 years as a senior investigator for the National Cancer Institute, both located in Bethesda, MD. He is an internationally recognized pioneer in the field of human cell transformation and his success in the development of cell culture systems has opened this field to the analysis of cellular, molecular and genetic mechanism of actions of chemical carcinogens, oncogenes and radiation.

Dr. Yendry Ventura oversees Abu Dhabi Stem Cells Center, the first fully integrated medical and research center focused on attaining the most leading and ambitious scopes in the fields of cell therapy in the UAE. A skilled scientific researcher in preforming, conducting, and analyzing in vivo and in vitro assays, as well as preclinical studies related to cell biology, immunology, cancer, and autoimmune diseases. Dr. Yendry has developed a new innovative methodology for harvesting stem cells through peripheral blood, this methodology was used in a clinical trial of COVID-19 patients and is known as UAECell-19 with Abu Dhabi Stem Cells Center as its sole owner. He also established the first bone marrow transplantation program in the UAE, known as AD-BMT. AD-BMT has intellectual property and is a comprehensive program designed to treat every patient in the UAE that may be eligible for the treatment. A Cuban national, Dr.Yendry received his medical degree from the “Victoria de Giron” Basic and Preclinical sciences institute. He has extensive knowledge in stem cell harvesting and isolation, using these techniques in the implementation of therapeutic and productive apheresis methods used in hematopoietic stem cells transplantations, as well as obtaining autologous stem cells for regenerative medicine. Dr.Yendry’s primary field of interest is in preclinical and clinical research such as clinical trials and compassionate protocols.

Will be updated soon...

Will be updated soon...

Dr. Vineet Datta brings over 20 years of global healthcare experience across clinical patient care, medical assistance, strategic leadership and healthcare consulting. His current role as the Executive Director at Datar Cancer Genetics is to globally expand the adoption of personal and accurate medicine across the clinical mainstream. He has been an active participant in innovative cancer data research being conducted globally across the Datar platform. He is a post-graduate in Internal Medicine from JN Medical College, Aligarh Muslim University, and has held various leadership positions across the NHS, International SOS and Apollo Hospitals. He was awarded Diplomas for Membership to the Royal College of Physicians, United Kingdom (MRCP-UK) and the Royal College of Emergency Medicine (MRCEM), London. Vineet is an elected Fellow the Royal College of Physicians and Surgeons, Glasgow, and possesses the Advanced Pre-hospital Emergency Care Certification from the Royal College of Surgeons, Edinburgh. He currently also serves as the International Advisor to the Royal College of Physicians and Surgeons of Glasgow, in additional to his professional responsibilities.